{"id":"lomustine-chemotherapy","safety":{"commonSideEffects":[{"rate":"60-80","effect":"Myelosuppression (thrombocytopenia, leukopenia)"},{"rate":"40-60","effect":"Nausea and vomiting"},{"rate":"40-50","effect":"Anemia"},{"rate":"1-5","effect":"Pulmonary fibrosis (delayed, cumulative)"},{"rate":"1-3","effect":"Secondary malignancy"},{"rate":"5-10","effect":"Hepatotoxicity"},{"rate":"5-10","effect":"Renal toxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lomustine forms covalent bonds with DNA bases, creating interstrand and intrastrand cross-links that block DNA replication and transcription. This leads to apoptosis in rapidly dividing cancer cells. As a lipophilic compound, it crosses the blood-brain barrier effectively, making it particularly useful for CNS malignancies.","oneSentence":"Lomustine is a nitrosourea alkylating agent that cross-links DNA strands, preventing cancer cell replication and inducing cell death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:49:35.007Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Brain tumors (glioblastoma, high-grade gliomas)"},{"name":"Hodgkin lymphoma"},{"name":"Non-Hodgkin lymphoma"},{"name":"Melanoma"}]},"trialDetails":[{"nctId":"NCT07448480","phase":"","title":"Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"Blokhin's Russian Cancer Research Center","startDate":"2026-02-01","conditions":"Recurrent Malignant Glioma, Glioblastoma, Anaplastic Astrocytoma","enrollment":1000},{"nctId":"NCT02724579","phase":"PHASE2","title":"Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-11-17","conditions":"Medulloblastoma","enrollment":45},{"nctId":"NCT05095376","phase":"PHASE3","title":"Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"NRG Oncology","startDate":"2022-03-28","conditions":"Glioblastoma, Gliosarcoma","enrollment":265},{"nctId":"NCT05331521","phase":"PHASE3","title":"A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).","status":"RECRUITING","sponsor":"University Hospital Heidelberg","startDate":"2021-04-07","conditions":"Oligodendroglioma","enrollment":406},{"nctId":"NCT04702581","phase":"PHASE3","title":"A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-12-07","conditions":"Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion","enrollment":280},{"nctId":"NCT02444000","phase":"PHASE3","title":"gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09-22","conditions":"Anaplastic Gliomas With 1p/19q Codeletion","enrollment":280},{"nctId":"NCT00887146","phase":"PHASE3","title":"Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2009-09","conditions":"Brain and Central Nervous System Tumors","enrollment":305},{"nctId":"NCT04049669","phase":"PHASE2","title":"Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG","status":"ACTIVE_NOT_RECRUITING","sponsor":"Theodore S. Johnson","startDate":"2019-10-02","conditions":"Glioblastoma, Medulloblastoma, Ependymoma","enrollment":130},{"nctId":"NCT02066220","phase":"PHASE2, PHASE3","title":"International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2014-06","conditions":"Brain Tumors","enrollment":360},{"nctId":"NCT05902169","phase":"PHASE3","title":"Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM","status":"ACTIVE_NOT_RECRUITING","sponsor":"CarThera","startDate":"2024-01-29","conditions":"Glioblastoma, Recurrent Glioblastoma, GBM","enrollment":560},{"nctId":"NCT04402073","phase":"PHASE2","title":"Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma","status":"TERMINATED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2022-11-11","conditions":"Medulloblastoma","enrollment":20},{"nctId":"NCT04863950","phase":"PHASE2","title":"Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2022-05-25","conditions":"Glioblastoma","enrollment":25},{"nctId":"NCT07120984","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma","status":"NOT_YET_RECRUITING","sponsor":"Philogen S.p.A.","startDate":"2026-01-30","conditions":"Glioma","enrollment":52},{"nctId":"NCT04762069","phase":"PHASE2","title":"A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme","status":"ACTIVE_NOT_RECRUITING","sponsor":"CNS Pharmaceuticals, Inc.","startDate":"2021-05-18","conditions":"Glioblastoma Multiforme, Adult","enrollment":210},{"nctId":"NCT03632135","phase":"PHASE3","title":"Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Cordgenics, LLC","startDate":"2018-05-20","conditions":"Recurrent Glioblastoma","enrollment":78},{"nctId":"NCT05427136","phase":"","title":"Early Pulmonary Dysfunction in Childhood Cancer Patients","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2021-06-01","conditions":"Pulmonary Dysfunction","enrollment":140},{"nctId":"NCT00085735","phase":"PHASE3","title":"Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-04-30","conditions":"Medulloblastoma","enrollment":549},{"nctId":"NCT03678883","phase":"PHASE2","title":"9-ING-41 in Patients with Advanced Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actuate Therapeutics Inc.","startDate":"2019-01-04","conditions":"Cancer, Pancreatic Cancer, Sarcoma","enrollment":350},{"nctId":"NCT03603795","phase":"PHASE2","title":"Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2018-10-11","conditions":"Acute Myeloid Leukemia","enrollment":110},{"nctId":"NCT03609060","phase":"PHASE2","title":"Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)","status":"ACTIVE_NOT_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2018-08-24","conditions":"Acute Myeloid Leukemia","enrollment":120},{"nctId":"NCT00003375","phase":"PHASE2, PHASE3","title":"Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"1998-10","conditions":"Brain and Central Nervous System Tumors","enrollment":370},{"nctId":"NCT06283927","phase":"","title":"The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)","status":"RECRUITING","sponsor":"Jasper Gerritsen","startDate":"2023-01-01","conditions":"Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype","enrollment":464},{"nctId":"NCT04530006","phase":"NA","title":"Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma","status":"UNKNOWN","sponsor":"CancerCare Manitoba","startDate":"2020-12-02","conditions":"Glioblastoma Multiforme","enrollment":20},{"nctId":"NCT03951142","phase":"PHASE2","title":"Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study","status":"UNKNOWN","sponsor":"Kyrre Eeg Emblem","startDate":"2019-10-01","conditions":"Glioblastoma, Brain Metastases","enrollment":165},{"nctId":"NCT05898451","phase":"PHASE2","title":"Effect of Refnot on Immunity in Cancer Patients","status":"COMPLETED","sponsor":"Refnot-Pharm Ltd","startDate":"2009-06-04","conditions":"Solid Tumor","enrollment":55},{"nctId":"NCT05410301","phase":"NA","title":"Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma","status":"WITHDRAWN","sponsor":"Varun Monga, MD","startDate":"2023-04","conditions":"Glioblastoma, Recurrent Glioblastoma","enrollment":""},{"nctId":"NCT01775475","phase":"PHASE2","title":"Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2016-09-15","conditions":"AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma","enrollment":7},{"nctId":"NCT05518383","phase":"PHASE4","title":"B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2022-05-25","conditions":"Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma","enrollment":300},{"nctId":"NCT02551718","phase":"NA","title":"High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-09-11","conditions":"Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia","enrollment":34},{"nctId":"NCT02796261","phase":"PHASE3","title":"Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients","status":"UNKNOWN","sponsor":"Orbus Therapeutics, Inc.","startDate":"2016-07","conditions":"Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma","enrollment":343},{"nctId":"NCT02212574","phase":"EARLY_PHASE1","title":"Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2017-04-04","conditions":"Medulloblastoma","enrollment":6},{"nctId":"NCT02678975","phase":"PHASE2, PHASE3","title":"Disulfiram in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2017-01","conditions":"Glioma, Glioblastoma","enrollment":88},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT00058370","phase":"NA","title":"Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-02","conditions":"Brain and Central Nervous System Tumors","enrollment":6},{"nctId":"NCT01614132","phase":"PHASE1, PHASE2","title":"Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults","status":"COMPLETED","sponsor":"University of Regensburg","startDate":"2009-01","conditions":"Medulloblastoma","enrollment":33},{"nctId":"NCT00004259","phase":"PHASE3","title":"Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2000-06","conditions":"Brain and Central Nervous System Tumors","enrollment":230},{"nctId":"NCT00031590","phase":"PHASE2","title":"Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2001-04","conditions":"Brain Tumors, Central Nervous System Tumors, Medulloblastoma","enrollment":30},{"nctId":"NCT03758014","phase":"PHASE2, PHASE3","title":"Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients","status":"UNKNOWN","sponsor":"Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd","startDate":"2018-11-27","conditions":"GBM","enrollment":200},{"nctId":"NCT00002569","phase":"PHASE3","title":"Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"1994-07","conditions":"Brain and Central Nervous System Tumors","enrollment":299},{"nctId":"NCT00335075","phase":"PHASE3","title":"Efficacy and Safety of Temodal vs Semustine in Subjects With Recurrent Glioblastoma or Anaplastic Astrocytoma (Study P03644)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-03-02","conditions":"Glioblastoma, Astrocytoma","enrollment":151},{"nctId":"NCT00074191","phase":"PHASE2","title":"Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma","status":"COMPLETED","sponsor":"OHSU Knight Cancer Institute","startDate":"2000-01","conditions":"Lymphoma","enrollment":1},{"nctId":"NCT00777153","phase":"PHASE3","title":"Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-10","conditions":"Recurrent Glioblastoma","enrollment":423},{"nctId":"NCT00002806","phase":"PHASE2","title":"Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"1996-07","conditions":"Brain and Central Nervous System Tumors","enrollment":43},{"nctId":"NCT01563614","phase":"PHASE1","title":"A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain","status":"TERMINATED","sponsor":"University Hospital, Bonn","startDate":"2012-03","conditions":"Leptomeningeal Metastasis From Malignant Melanoma","enrollment":1},{"nctId":"NCT00317408","phase":"NA","title":"Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma","status":"UNKNOWN","sponsor":"European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma","startDate":"2004-04","conditions":"Lymphoma","enrollment":96},{"nctId":"NCT02333513","phase":"NA","title":"A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation","status":"UNKNOWN","sponsor":"Hebei Yanda Hospital","startDate":"2015-02","conditions":"Recurrent High-grade Glioma","enrollment":100},{"nctId":"NCT00005796","phase":"PHASE1","title":"Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors","status":"COMPLETED","sponsor":"Indiana University","startDate":"2000-02","conditions":"Bone Marrow Suppression, Brain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ","enrollment":10},{"nctId":"NCT00761280","phase":"PHASE3","title":"Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma","status":"TERMINATED","sponsor":"Isarna Therapeutics GmbH","startDate":"2008-12","conditions":"Anaplastic Astrocytoma, Glioblastoma","enrollment":27},{"nctId":"NCT00002875","phase":"PHASE3","title":"Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-12","conditions":"Brain Tumors, Central Nervous System Tumors","enrollment":421},{"nctId":"NCT00053872","phase":"PHASE3","title":"Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2003-02","conditions":"Brain and Central Nervous System Tumors","enrollment":316},{"nctId":"NCT00590837","phase":"PHASE3","title":"Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2008-02","conditions":"Acute Myeloid Leukemia","enrollment":459},{"nctId":"NCT00006024","phase":"PHASE1","title":"Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-11","conditions":"Brain Tumor, Central Nervous System Tumor","enrollment":32},{"nctId":"NCT00303810","phase":"NA","title":"Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2001-01","conditions":"Brain and Central Nervous System Tumors","enrollment":567},{"nctId":"NCT00278278","phase":"PHASE3","title":"Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2003-09","conditions":"Brain and Central Nervous System Tumors","enrollment":150},{"nctId":"NCT00431561","phase":"PHASE2","title":"Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma","status":"COMPLETED","sponsor":"Isarna Therapeutics GmbH","startDate":"2003-04","conditions":"Glioblastoma, Anaplastic Astrocytoma","enrollment":141},{"nctId":"NCT00003788","phase":"PHASE3","title":"Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas","status":"UNKNOWN","sponsor":"Colorado Health Foundation","startDate":"1998-04","conditions":"Brain and Central Nervous System Tumors","enrollment":270},{"nctId":"NCT00003603","phase":"PHASE3","title":"Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma","status":"UNKNOWN","sponsor":"Riverside Haematology Group","startDate":"1998-03","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":660},{"nctId":"NCT00276666","phase":"PHASE2","title":"Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2001-11","conditions":"Brain and Central Nervous System Tumors","enrollment":29},{"nctId":"NCT00002944","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Progressive Brain Tumors","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1997-04","conditions":"Brain Tumors, Central Nervous System Tumors","enrollment":428},{"nctId":"NCT00274911","phase":"PHASE2","title":"Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors","status":"UNKNOWN","sponsor":"Children's Cancer and Leukaemia Group","startDate":"2004-02","conditions":"Brain and Central Nervous System Tumors","enrollment":30},{"nctId":"NCT00003101","phase":"PHASE2","title":"Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1997-08","conditions":"Brain and Central Nervous System Tumors","enrollment":60},{"nctId":"NCT00427570","phase":"PHASE3","title":"Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery","status":"COMPLETED","sponsor":"NSABP Foundation Inc","startDate":"1977-09","conditions":"Colorectal Cancer","enrollment":""},{"nctId":"NCT01737346","phase":"PHASE2","title":"Procarbazine and Lomustine in Recurrent Glioblastoma","status":"UNKNOWN","sponsor":"Incheon St.Mary's Hospital","startDate":"2012-10","conditions":"Recurrent Glioblastoma Multiforme","enrollment":52},{"nctId":"NCT00002840","phase":"PHASE3","title":"Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"1996-08","conditions":"Brain and Central Nervous System Tumors","enrollment":350},{"nctId":"NCT00003929","phase":"PHASE2","title":"Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma","status":"WITHDRAWN","sponsor":"Case Comprehensive Cancer Center","startDate":"1998-06","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT00003113","phase":"PHASE2","title":"Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"1997-07","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT00003114","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"1997-07","conditions":"Lymphoma","enrollment":5},{"nctId":"NCT00049439","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"1998-03","conditions":"Lymphoma","enrollment":54},{"nctId":"NCT00418743","phase":"","title":"Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)","status":"UNKNOWN","sponsor":"Groupe Francais De Pneumo-Cancerologie","startDate":"2005-12","conditions":"Small Cell Lung Cancer","enrollment":138},{"nctId":"NCT00503204","phase":"PHASE1","title":"Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-09","conditions":"Recurrent Glioblastoma, Brain Tumor","enrollment":20},{"nctId":"NCT00989352","phase":"PHASE2","title":"Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma","status":"UNKNOWN","sponsor":"University Hospital Freiburg","startDate":"2009-09","conditions":"Primary Non Hodgkin Lymphoma of the Central Nervous System","enrollment":56},{"nctId":"NCT00700544","phase":"PHASE3","title":"Treatment Outcome in Elderly Patients","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2002-06","conditions":"AML, Elderly Patients","enrollment":330},{"nctId":"NCT00068952","phase":"PHASE3","title":"Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Pfizer","startDate":"2003-08","conditions":"Glioblastoma","enrollment":118},{"nctId":"NCT00480064","phase":"PHASE3","title":"Lomustine and Intermediate Dose Cytarabine in Older Patients With AML","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","startDate":"1995-07","conditions":"Acute Myeloid Leukemia","enrollment":360}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Lomustine Chemotherapy","genericName":"Lomustine Chemotherapy","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lomustine is a nitrosourea alkylating agent that cross-links DNA strands, preventing cancer cell replication and inducing cell death. Used for Brain tumors (glioblastoma, high-grade gliomas), Hodgkin lymphoma, Non-Hodgkin lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}